Article Text

other Versions

PDF
Systematic review
Meta analysis suggests that folic acid supplementation does not reduce risk of stroke, but there may be some benefit when given in combination with vitamins B6 and B12 and in primary prevention
  1. Gustavo Saposnik
  1. Stroke Outcomes Research Unit, St. Michael's Hospital, University of Toronto, Toronto, Canada
  1. Correspondence to Gustavo Saposnik
    55 Queen St East, Suite 931, St Michael's Hospital, University of Toronto, Toronto M5C 1R6, Canada; saposnikg{at}smh.ca

Statistics from Altmetric.com

Commentary on:

Hyperhomocysteinemia has been associated with premature atherosclerosis with an increased risk of cardiovascular events.1,,3 Folate and cyanocobalamin (vitamin B12) are important regulators of the metabolism of homocysteine, and studies have shown an inverse relationship between levels of these factors and levels of homocysteine in the blood.4 5 On the basis of epidemiological studies, clinicians and scientists expected that homocysteine-lowering therapy (HLT) would reduce the incident risk of cardiovascular diseases (including stroke). As a result, HLT has been tested in several randomised clinical trials.6,,9

Methods

In the present study, Lee and colleagues report the results of a meta-analysis including randomised, controlled trials assessing the efficacy of folic acid supplementation in the prevention of stroke. They used a strict inclusion criteria: (1) randomised, controlled study; (2) comparison of folic acid supplementation (with or without vitamins B6 and B12) with inactive or low-dose control; (3) the duration of the intervention was longer than 6 months; and (4) study reporting on the number of stroke events in both active …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.